Channel - Med/Surg Telehealth Lectures
10/14/2019 3:39:37 PM

Channel Videos

20121024-Med/Surg:Cancer and Venous Thromboembolism - S. moll - 20121024
Objectives: 1) decide which anticoagulant to use in patients with cancer and acute venous thromboembolism; 2) discuss which patient with asymptomatic venous thromboembolism, discovered on cancer screening radiological testing, should undergo anticoagulation therapy and which one not. 3) list the indications for IVC filter placement and discuss the absolute and relative contraindications; 4) discuss the pros and cons of the new oral anticoagulants.
Stephan Moll MD
10/24/2012 4:00:00 PM

Accrual to Cancer Clinical Trials - K. Amos - 20120822
Objectives: • Discuss the importance of clinical trials for cancer care • Describe national statistics on accrual rates to cancer clinical trials • Review types of clinical trials • Identify challenges and barriers to sponsoring clinical trials • Examine barriers to accrual of minorities in cancer clinical trials
Keith Amos MD
8/22/2012 2:45:00 PM

Acute Myeloid Leukemia (AML): Finally Making Progress? - J. Zeidner - 20180523
Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy that affects approximately 20,000 patients each year in the United States. Management of AML has changed little over the last several decades and outcomes remain unsatisfactory. However, recent drug discoveries and approvals show tremendous promise. This presentation will review the current treatment armamentarium of AML highlighting novel concepts and investigational agents in development.
UNCCN Mediasite Presenter
5/23/2018 3:30:00 PM

Acute Myeloid Leukemia: An Overview and Updates - M. Foster - 20170222
This presentation provides information to assist clinicians in identifying patients with Acute Myeloid Leukemia and selecting appropriate treatment options based on clinical and genetic variables. The presentation also reviews appropriate criteria for investigational/novel therapies and non-cytotoxic therapies, including stem cell transplantation, using cytogenetics and other variables. Lecture Objective: -Differentiate, among patients with Acute Myeloid Leukemia, those with favorable, intermediate, or unfavorable disease biology based on clinical, cytogenetic, and molecular genetic variables. -Identify patients with Acute Myeloid Leukemia likely to benefit from cytotoxic induction chemotherapy, and those unlikely to benefit from induction chemotherapy who are candidates for investigational or non-cytotoxic therapies. -Select appropriate patients with Acute Myeloid Leukemia for referral to consider stem cell transplantation. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Matthew Foster MD
2/22/2017 4:30:00 PM

Advances in Melanoma Cancer Treatment - F. Collichio - 20171115
This presentation reviews melanoma from diagnosis through treatment using a case study approach. The speaker reviews AJCC staging guidelines, basic biologic principles, various treatment options, and side effects of treatment. The content includes what’s new for melanoma management and thoughts on future research directions. Learning Outcomes: • Review the ABCDEs for melanoma. • Know the standard of care for each stage of disease including the new treatments for stage III. • Know how to recognize the side effects of therapy. This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Francis Collichio MD
11/15/2017 4:30:00 PM

Advances in Neuro Oncology - J. Wu - 20130925
Objectives: 1. Discuss the current standard of care for malignant glinomas and brain metastases 2. Review the progress in the field of neuro-oncology 3. Review the clinical trial portfolio of the UNC Neuro-Oncology Program
Jing Wu MD, PhD
9/25/2013 3:55:00 PM

Aerobic and Resistance Exercise in Cancer Patients: Methods and Benefits - B. Wood and C. Battaglini - 20181024
In this presentation, Dr. Wood and Dr. Battaglini will review the importance of physical function (also referred to as physical performance) in patients receiving treatment for cancer, followed by a review of the mechanisms and evidence base supporting the role of exercise in improving cancer outcomes. Examples of aerobic and resistance exercise interventions will be discussed.
Claudio Battaglini PhD
10/24/2018 3:30:00 PM

An Overview of Melanoma, with an emphasis on the systemic treatments - F. Collichio - 20141022
This lecture will discuss the causes and prevalance of malignant melanoma and talk about the treatment methods for the different stages. Learning Outcomes: 1. Recognize melanoma skin cancer. 2. Describe broad treatment by stage. 3. Know the different categories of systemic treatment. 4. Manage the side effects of therapy. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Francis Collichio MD
10/22/2014 3:55:00 PM

ASCO 2012 Update:Hottest topics in the Treatment of Lung Cancer - J. Weiss - 20120725
Objectives: 1. Identify new treatment methods for lung cancer after initial chemotherapy 2. Discuss optimal treatment of patients with limited functional status 3. Recognize that new molecular targets in NSCLC are adding new treatment options
Jared Weiss MD
7/25/2012 5:17:00 PM

Breast Cancer Update:New Targeted Therapies, Side Effects and Survivorship Issues - C. Dees - 20130724
Objectives: 1. The participant will learn about the benefits of the newest targeted therapies used for the treatment of breast cancer 2. The participant will learn about the side effects of the newest targeted therapies along with strategies to minimize these side effects 3. The participant will learn about the interdisciplinary resources available to deal with survivorship issues related to breast cancer
Claire Dees MD, MSc
7/24/2013 4:00:00 PM

Cancer Pain Management - D. L. James - 20160525
This lecture will discuss the epidemiology and pathophysiology of cancer pain and focus on the principles of multimodal analgesia. Dr. James will also elucidate novel therapies in cancer pain management. Learning Outcomes: • Discuss epidemiology and pathophysiology of cancer pain. • Explain principles of multimodal analgesia. • Elucidate novel therapies in cancer pain management. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Dominika L James MD
5/25/2016 3:30:00 PM

Cardiovascular toxicity of targeted cancer therapies: Clinical considerations and potential mechanisms - B. Jensen - 20190925
When there is damage to the heart muscle, we call this cardiotoxicity. Brian Jensen, MD, will talk about underlying mechanisms for the cardiotoxicity of kinase inhibitors used to treat cancer.
UNCCN Mediasite Presenter
9/25/2019 3:30:00 PM

Comprehensive Assessment of the Geriatric Oncology Patient - T. Jolly - 20130522
Objectives: 1. Understand the value of geriatric assessment in the care of older cancer patients 2. Explain how geriatric assessment can be applied to routine oncology practice 3. Identify how geriatric assessment can guide interventions to improve the outcomes
Trevor Jolly MBBS
5/22/2013 3:55:00 PM

Evolution of Novel Radiation Strategies to Improve the Therapeutic Ratio - L. Marks - 20130227
Objectives: 1. Explain the role of uncertainty in how radiation therapy is delivered 2. Describe recent advances in radiation therapy and how they are intended to reduce uncertainty 3. Identify the risks of some of the new technologies
Larry Marks MD
2/27/2013 5:00:00 PM

GU Cancers: Best of ASCO - M. Milowsky - 20180425
UNCCN Mediasite Presenter
4/25/2018 3:30:00 PM

How I Treat Lymphoma - S. Park - 20130424
Objectives: 1. Describe basic information about lymphoma 2. Discuss how lymphoma is diagnosed, classified, and staged 3. Identify new treatments and clinical trials in lymphoma
Steve Park MD
4/24/2013 3:55:00 PM

Immunological Mechanisms in Pancreatic Cancer - Y. P. Gupta - 20190327
This lecture will review the current understanding of the role of immune system in pancreatic cancer and provide insight into development of the latest immune-based therapies aimed at treating patients with pancreatic cancer.
UNCCN Mediasite Presenter
3/27/2019 3:30:00 PM

Impact of Patient Reported Outcomes on Patient Care - E. Basch - 20170524
This lecture will provide an overview of current news and advances in patient-reported outcomes research. Patient-reported outcomes includes assessment of patient symptoms, adverse events, functional status, and overall quality of life. The presentation will also discuss ways patient-reported outcomes can be used to assess and improve patient care specific to oncology patients. Lecture Objectives: -Explain the value of patient symptom reporting. -Describe electronic communication systems for symptom management. -Recognize national efforts to develop PRO systems in EHRs. This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Ethan Basch MD
5/24/2017 3:30:00 PM

Improving Outcomes In Radical Cystectomy - R. S. Pruthi - 20190424
The lecture will evaluate the recent improvements in patients undergoing radical cystectomy for bladder cancer (including peri-operative chemotherapy and robotic surgery), and will describe some of the obstacles to providing optimal care that still exist.
Raj S. Pruthi, MD
4/24/2019 3:30:00 PM

Indications for Cyberknife Radiation - R. Chen - 20120523
Objectives: 1) Describe Cyberknife radiation 2) Discuss potential uses of Cyberknife radiation in different cancers including lung cancer, prostate cancer and treatment of metastatic disease 3) Described published literature demonstrating patient outcomes after Cyberknife treatment
Ron Chen MD, MPH
5/23/2012 4:00:00 PM

Infections in Cancer Patients - D. V. Duin - 20161116
This lecture discusses infections in cancer patients, including practice guidelines for management of neutropenia and hematopoietic stem cell transplantation. This presentation also discusses antibiotic resistance, antimicrobial stewardship, and infection control relevant to patients with cancer. Learning Outcomes: • Describe the epidemiology of infections in patients with cancer. • Discuss risk factors for infection in patients with cancer. • Identify methods of decreasing risk of infection in patients with cancer. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
David van Duin MD, PhD
11/16/2016 4:30:00 PM

Lymphoma: New treatments and clinical trials, including an update from ASH 2011 - K. Richards - 20120222
Objectives: 1. Identify current lymphoma diagnosis and treatment 2. Describe new therapies for lymphoma 3. Discuss clinical trials and therapies development
Kristy Richards PhD
2/22/2012 7:00:00 PM

Med/Surg:Genomics and Breast Cancer - C. Perou - 20130123
Objectives: 1. Discuss the basics of genome sequencing based upon short read mapping approach 2. Describe how genome sequencing may be used as a biomarker of response
Chuck Perou PhD
1/23/2013 5:00:00 PM

Meeting the Unique Needs of Pediatric Oncology Patient - T. Alexander - 20180328
Every year, an estimated 250,000+ new cases of cancer affect children under the age of 20 worldwide. This presentation provides an overview of common pediatric oncology diseases, the general outcomes, and recent treatment advances.
John Alexander, MD,MPH
3/28/2018 3:30:00 PM

Metastatic Breast Cancer - C. Dees - 20171213
This presentation discusses management of metastatic breast cancer. The presenter will provide a review of current systemic therapy options and will review advances in management strategies, including ongoing studies, for metastatic breast cancer. Learning Outcomes: • Understand systemic therapy options for HR+ Her2- metastatic breast cancer. • Understand systemic therapy options for Her2+ metastatic breast cancer. • Understand systemic therapy options for triple negative metastatic breast cancer. This presentation is presented as part of Medical and Surgical Oncology Lecture series.
Claire Dees MD, MSc
12/13/2017 4:30:00 PM

Metastatic Breast Cancer - L. Carey - 20190626
Of women diagnosed with early-stage breast cancer, almost 30% will develop metastatic disease. Genomic testing of metastatic breast cancer will help us determine which forms of breast cancer are likely to return in other parts of the body.
Lisa Carey MD
6/26/2019 3:30:00 PM

Neoadjuvant Approaches to Breast Cancer: When, Why and How - L. Carey and D. Ollila - 20141119
This lecture will discuss Neoadjuvant therapy and its advantages in minimizing surgery. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Lisa Carey MD
11/19/2014 4:55:00 PM

New Options for Immunotherapy: Where We Are and Where We’re Going - B. Vincent - 20170726
Benjamin Vincent MD
7/26/2017 3:30:00 PM

Non-Muscle Invasive Bladder Cancer: Diagnostic and Treatment Strategies - A. Smith - 20150527
This lecture discusses the unmet need for new treatment options associated with fewer complications, better patient compliance, and increased prevention of recurrence in non-muscle invasive bladder cancer. Objectives: 1. Explain risk stratification of non-muscle invasive bladder cancer (NMIBC) 2. Discuss about urinary markers and cystoscopic enhancement techniques in diagnosis and management of NMIBC 3. Describe the treatment guidelines involved with NMIBC, including intravesical therapies, surgical procedures, and surveillance. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
UNCCN Mediasite Presenter
5/27/2015 3:30:00 PM

Novel Molecularly Targeted Therapies and Biomarkers in Advanced Colorectal Cancer - M. S. Lee - 20180725
Treatment of metastatic colorectal cancer has continued to evolve over the last several years, with emerging identification of biomarkers that underlie heterogeneity of responses to new and existing therapy. Ongoing clinical research seeks to identify new therapeutic options in molecularly-defined subgroups of patients. We will review the most exciting and clinically impactful research findings in this presentation.
Michael Lee ,MD
7/25/2018 3:30:00 PM

Optimizing Care for the Older Cancer Patient - T. Jolly and H. Muss - 20140226
Trevor Jolly MBBS
2/26/2014 4:55:00 PM

Promising New Treatment Options for Rectal Cancer - K. Stitzenberg - 20170322
The information presented in this lecture is designed to assist the health care provider in understanding treatments for rectal cancer. This program will review the standard of care for rectal cancer based on staging and discuss emerging and investigational treatment paradigms. Lecture Objectives: -Discuss emerging treatment paradigms for rectal cancer with understanding of what is standard of care and what is still investigational. -Discuss new surgical approaches to rectal cancer with understanding of what is standard of care and what is still investigational. -Discuss the potential risks and benefits of emerging treatment paradigms. This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Karyn Stitzenberg MD, MPH, FACS
3/22/2017 3:30:00 PM

Psychopharmacology in the Oncology Setting - D. Rosenstein - 20121128
Objectives: 1) Describe and discuss key principles of psychopharmacology 2) Identify the first-line pharmacological treatments for common psychiatric syndromes in patients with cancer 3) Discuss the important safety considerations for using psychotropics in the oncology setting
Donald Rosenstein MD
11/28/2012 5:00:00 PM

Recent Advances on the Gut Microbiome and Cancer Therapy - T. O. Keku - 20180822
The gut microbiome is responsible for regulation of many functions in humans including metabolism, immune responses and inflammation. This lecture will focus on the gut microbiome and their interactions with the host to influence cancer treatment outcomes.
Temitope O. Keku PhD, MSPH
8/22/2018 3:30:00 PM

Renal Cell Carcinoma: Past, Present, and Future - T. Rose - 20170823
Information presented in this presentation is designed to increase knowledge about renal cell carcinoma (RCC). Information focuses on risk factors associated with RCC, the standard treatments for both localized and metastatic disease, and the future for RCC treatment. Learning Outcomes: • State the risk factors for kidney cancer, including the genetic syndromes associated with renal cell carcinoma. • Discuss the current status of adjuvant treatment for high-risk localized kidney cancer. • State the standard first- and second-line systemic therapies for metastatic kidney cancer. This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Tracy Rose MD,MPH
8/23/2017 3:30:00 PM

Sarcoma: A Primer on this Motley Crew of Cancers - J. G. Olson - 20131023
Objectives: 1. Describe the general classification of sarcomas 2. Identify the principles of sarcoma evaluation & therapy 3. Describe future directions of sarcoma therapy
Juneko Grilley-Olson MD
10/23/2013 4:00:00 PM

Sickle Cell Disease: An Overview and Updates - K. Ataga - 20170125
The CDC estimates that Sickle Cell Disease affects approximately 100,000 Americans. This lecture will provide an overview of this group of inherited red blood cell disorders along with updates on current research in the field. Lecture Objectives: -Identify the various sickle cell syndromes. -Describe the pathophysiology of sickle cell disease. -Implement the NHLBI evidence-based guidelines for management of sickle cell disease. This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Kenneth Ataga MBBS
1/25/2017 4:30:00 PM

The ABCs of BMT - S. Sharf - 20130626
Objectives: 1. Describe the difference between an autologous and an allogeneic bone marrow/stem cell transplant 2. Identify at least three (3) diseases that could be treated by a bone marrow/stem cell transplant 3. Define at least three (3) barriers to obtaining a suitable allogeneic donor
Sam Sharf RN, BSN, CHTC
6/27/2013 3:55:00 AM

The Role of Radiation Therapy in Advanced and Metastatic Disease - K. Pearlstein - 20171025
This presentation discusses common palliative radiation treatments, techniques, and toxicities. The content reviews current guidelines for the use of radiation in advanced and metastatic disease as well as oligometastatic disease. Learning Outcomes: • Identify symptoms that can be effectively treated with palliative radiotherapy and describe common palliative treatment approaches. • Recognize the role of radiation in providing local control for locally advanced and oligometastatic disease. • Recognize acute and late toxicities of radiotherapy for different treatment sites. This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Kevin Pearlstein MD
10/25/2017 3:30:00 PM

Treatment of Advanced and Recurrent Rectal Cancer - B. Calvo - 20131120
Benjamin Calvo MD
11/20/2013 4:55:00 PM

Treatment of Relapsed and Refractory Multiple Myeloma - B. Reeves - 20170628
Purpose: This presentation discusses current strategies for managing relapsed and refractory multiple myeloma. Update are provided on appropriate chemotherapy regimens for relapsed and refractory multiple myeloma, including new options of treatment for this disease. The presentation also reviews factors influencing treatment, including when treatment should be initiated and discontinued. Learning Outcomes: -Determine when to start treatment in the context of relapsed multiple myeloma. -Identify appropriate chemotherapy regimens for relapsed multiple myeloma. -Understand new drugs in clinical trial for relapsed and refractory multiple myeloma. This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Brandi Reeves MD
6/28/2017 3:30:00 PM

Tumor Treating Fields for Glioblastoma - Simon Khagi - 20180926
Glioblastoma is a devastating disease with a survival that is measured in months. The recent FDA approval of the Optune device for the treatment of newly-diagnosed glioblastoma was a paradigm shift in the field of neuro-oncology. We will focus our discussion on the biological underpinnings of this device and clinical data supporting its use.
Simon Khagi, MD
9/26/2018 3:30:00 PM

Understanding and Treating Anxiety & Depression in Patients and Families with Advanced Cancer - E. Park - 20181128
Dr. Park will review the presenting symptoms, diagnostic approach, and initial management of anxiety and depressive disorders in patients and families affected by cancer. She will additionally review challenges specific to the management of patients with advanced or terminal cancer. For continuing education credits for this and other lectures, please visit our Learning Portal at
Leeza Park MD
11/28/2018 4:30:00 PM

Update on Advanced Bladder Cancer - M. Milowsky - 20120328
Objectives: 1. Explain the management of patients with locally advanced/metastatic urothelial carcinoma of the bladder. 2. Discuss the treatment of patients with advanced bladder cancer who are ineligible for cisplatin-based chemotherapy. 3. Describe the use of perioperative chemotherapy in the management of patients with muscle-invasive bladder cancer including a discussion of the underutilization of neoadjuvant chemotherapy.
Matt Milowsky MD
3/28/2012 4:00:00 PM

Update on CAR T Therapy - N. Grover - 20181219
This lecture will give an overview of CAR-T cells, discuss recent clinical trial results and FDA approvals as well as current clinical applications. This lecture will also cover the management of the unique toxicities of CAR-T therapy. Finally, this lecture will discuss some of the ongoing trial of CAR-T therapy as well as future directions of the field. For continuing education credits for this and other lectures, please visit our Learning Portal at
UNCCN Mediasite Presenter
12/19/2018 4:30:00 PM

Update on Colorectal Cancer: Current Treatment Strategies and Clinical Trials - A. McRee - 20120425
Objectives 1. Describe epidemiology and staging of colorectal cancer 2. Identify adjuvant therapy and mismatch repair status 3. Describe treatment strategies including new therapeutic targets and clinical trials
Autumn McRee MD
4/25/2012 9:00:00 PM

Updates in Gynecologic Oncology - W. Brewster - 20150826
This lecture will discuss the prevalence of gynecological cancers in the US and the role that obesity plays in these numbers. The discussion will also review the surgical, chemotherapy, and biological options for epithelial ovarian cancer and recurrent endometrial cancer. Learning Outcomes: • Discuss surgical therapies for gynecologic malignancies • Describe chemotherapy and radiation options for gynecologic malignancies • Identify new developments in genetics This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
UNCCN Mediasite Presenter
8/26/2015 3:30:00 PM

Updates in Melanoma treatment for patients with advanced disease - F. Collichio - 20120926
Objectives: 1. Identify and describe the different options for therapy for advanced melanoma 2. Describe side effects of melanoma treatment and discuss interventions to manage them 3. Describe why melanoma is still a devastating disease and the continued need for more research into this disease
Francis Collichio MD
9/26/2012 4:00:00 PM

Using Biomarkers to Plan Adjuvant Therepy in Breast Cancer - L. A. Carey - 20180627
It is difficult to determine whether a primary therapy has suppressed or killed a cancer. Adjuvant therapy can further improve the chances that the cancer will not return. In this presentation Dr. Cary will discuss which adjuvant therapy options are available for breast cancer patients as well as some of the recent developments in adjuvant therapy.
Lisa Carey MD
6/27/2018 3:30:00 PM

Which Patients to Refer for Stem Cell Transplantation and When - T. Shea - 20131009
Objectives: 1. Discuss the current data on outcomes of stem cell transplant in various diseases 2. Identify which patients are best suited for transplant referral 3. Describe the optimal time to refer patients for evaluation for stem cell transplantation
Thomas Shea MD, Director of the UNC Cancer Network
10/9/2013 4:00:00 PM

Mediasite Showcase
Mediasite's the trusted cornerstone of any campus or enterprise video strategy. Our unyielding commitment to all things video helps you transform education, training, communications and online events.
Webcasting Video Content Management Video Delivery Integration Services Mediasite Community
Powered By Mediasite - Enterprise Video Platform
Sonic Foundry